Paper47611
The clinical pharmacology of antineoplastic agents (second of two parts).
Chabner BA and 3 others. N Engl J Med, 1975. Cited by 113 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The clinical pharmacology of antineoplastic agents (second of two parts). Papers, record 47611. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/47611
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Antineoplastic Agents | Major topic |
| Cyclophosphamide | Major topic |
| Animals | |
| Azacitidine | |
| Bleomycin | |
| Carmustine | |
| Cell Nucleus | |
| Chemical Phenomena | |
| Chemistry | |
| Cyclohexanes | |
| Cytarabine | |
| DNA, Neoplasm | |
| Doxorubicin | |
| Humans | |
| Neoplasms | |
| Nitrosourea Compounds |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33,982,817 | Metabolomics in cancer research and emerging applications in clinical oncology. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33982817 | PubMed |
| 28,118,117 | The Radiation Stress Response: Of the People, By the People and For the People. | Radiat Res | 2017 | https://conductscience.org/library/papers/28118117 | PubMed |
| 24,277,178 | The potential of nucleotide analogs as inhibitors of retroviruses and tumors. | Pharm Res | 1984 | https://conductscience.org/library/papers/24277178 | PubMed |
| 23,822,983 | Serine, glycine and one-carbon units: cancer metabolism in full circle. | Nat Rev Cancer | 2013 | https://conductscience.org/library/papers/23822983 | PubMed |
| 7,337,968 | The effect of chronic daily cyclophosphamide administration on established antibody responses. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7337968 | PubMed |
| 6,731,586 | Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation. | Am J Pathol | 1984 | https://conductscience.org/library/papers/6731586 | PubMed |
| 6,288,384 | Massive bilateral nephroblastomatosis in a 13-year-old-girl. | Eur J Pediatr | 1982 | https://conductscience.org/library/papers/6288384 | PubMed |
| 6,275,617 | Chemotherapy of lung cancer. | Yale J Biol Med | 1981 | https://conductscience.org/library/papers/6275617 | PubMed |
| 2,378,842 | High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease. | Br J Ophthalmol | 1990 | https://conductscience.org/library/papers/2378842 | PubMed |
| 535,124 | Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/535124 | PubMed |
| 475,958 | Tumour site and renal dysfunction as factors influencing leucopenia after chemotherapy for Burkitt's lymphoma. | Br J Cancer | 1979 | https://conductscience.org/library/papers/475958 | PubMed |
| 456,408 | The protein binding of methotrexate by the serum of normal subjects. | Eur J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/456408 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/47611
GET https://conductscience.org/api/papers/v1/47611/authors